184 related articles for article (PubMed ID: 19709134)
21. Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.
Petty SJ; Kantor S; Lawrence KM; Berkovic SF; Collins M; Hill KD; Makovey J; Sambrook PN; O'Brien TJ; Wark JD
Epilepsia; 2014 Oct; 55(10):1551-7. PubMed ID: 25124647
[TBL] [Abstract][Full Text] [Related]
22. Endocrine effects of valproate in adolescent girls with epilepsy.
de Vries L; Karasik A; Landau Z; Phillip M; Kiviti S; Goldberg-Stern H
Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
24. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
25. Thyroid hormone levels in children receiving carbamazepine or valproate.
Aggarwal A; Rastogi N; Mittal H; Chillar N; Patil R
Pediatr Neurol; 2011 Sep; 45(3):159-62. PubMed ID: 21824562
[TBL] [Abstract][Full Text] [Related]
26. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
27. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Guo CY; Ronen GM; Atkinson SA
Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
[TBL] [Abstract][Full Text] [Related]
28. Lack of valproic acid-associated weight gain in prepubertal children.
Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of renal tubular function in children taking anti-epileptic treatment.
Unay B; Akin R; Sarici SU; Gok F; Kurt I; Gokcay E
Nephrology (Carlton); 2006 Dec; 11(6):485-8. PubMed ID: 17199783
[TBL] [Abstract][Full Text] [Related]
30. The role of ghrelin in weight gain and growth in epileptic children using valproate.
Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
[TBL] [Abstract][Full Text] [Related]
31. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
Krishnamoorthy G; Nair R; Sundar U; Kini P; Shrivastava M
Neurol India; 2010; 58(2):213-9. PubMed ID: 20508338
[TBL] [Abstract][Full Text] [Related]
32. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine.
Cansu A; Serdaroglu A; Cinaz P
Eur J Paediatr Neurol; 2011 Nov; 15(6):527-31. PubMed ID: 21703891
[TBL] [Abstract][Full Text] [Related]
33. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate.
Cansu A; Serdaroğlu A; Camurdan O; Hirfanoğlu T; Bideci A; Gücüyener K
Epilepsia; 2006 Nov; 47(11):1855-9. PubMed ID: 17116024
[TBL] [Abstract][Full Text] [Related]
34. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy.
Attilakos A; Papakonstantinou E; Schulpis K; Voudris K; Katsarou E; Mastroyianni S; Garoufi A
Epilepsy Res; 2006 Oct; 71(2-3):229-32. PubMed ID: 16889940
[TBL] [Abstract][Full Text] [Related]
35. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
36. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Kafali G; Erselcan T; Tanzer F
Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy.
Gough H; Goggin T; Bissessar A; Baker M; Crowley M; Callaghan N
Q J Med; 1986 Jun; 59(230):569-77. PubMed ID: 3092278
[TBL] [Abstract][Full Text] [Related]
38. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
[TBL] [Abstract][Full Text] [Related]
39. Endocrine Effects of Valproate versus Carbamazepine in Males with Epilepsy: A Prospective Study.
Goldberg-Stern H; Itzhaki T; Landau Z; de Vries L
Horm Res Paediatr; 2015; 83(5):332-9. PubMed ID: 25792241
[TBL] [Abstract][Full Text] [Related]
40. Best practice guidelines for the management of women with epilepsy.
Crawford P
Epilepsia; 2005; 46 Suppl 9():117-24. PubMed ID: 16302885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
